1,127 results on '"García JL"'
Search Results
2. Bouveret's syndrome and digestive endoscopy as diagnostic support
- Author
-
García Martínez, A, primary, Mateos Millán, D, additional, Morales Prado, Á, additional, and Prieto García, JL, additional
- Published
- 2024
- Full Text
- View/download PDF
3. Transcriptional response of the xerotolerant Arthrobacter sp. Helios strain to PEG-induced drought stress
- Author
-
Hernández-Fernández, G, primary, Galán, B, additional, Carmona, M, additional, Castro, L, additional, and García, JL, additional
- Published
- 2022
- Full Text
- View/download PDF
4. Benchtop nuclear magnetic resonance-based metabolomic approach for the diagnosis of bovine tuberculosis
- Author
-
Ruiz-Cabello, J, Sevilla, IA, Olaizola, E, Bezos, J, Miguel-Coello, AB, Muñoz-Mendoza, M, Beraza, M, Garrido, JM, and Izquierdo-García, JL.
- Abstract
Even though enormous efforts and control strategies have been implemented, bovine tuberculosis (TB) remains a significant source of health and socioeconomic concern. The standard method used in TB eradication programs for in vivo detection is the tuberculin skin test. However, the specificity of the tuberculin skin test is affected by infection with non-tuberculous mycobacteria or by vaccination. Thus, some animals are not correctly diagnosed. This study aimed first to identify a plasma metabolic TB profile by high-field (HF) nuclear magnetic resonance (NMR) spectroscopy and second measure this characteristic TB metabolic profile using low-field benchtop (LF) NMR as an affordable molecular technology for TB diagnosis. Plasma samples from cattle diagnosed with TB (derivation set, n = 11), diagnosed with paratuberculosis (PTB, n = 10), PTB-vaccinated healthy control (n = 10) and healthy PTB-unvaccinated control (n = 10) were analyzed by NMR. Unsupervised Principal Component Analysis (PCA) was used to identify metabolic differences between groups. We identified 14 metabolites significantly different between TB and control animals. The second group of TB animals was used to validate the results (validation set, n = 14). Predictive models based on metabolic fingerprint acquired by both HF and LF NMR spectroscopy successfully identified TB versus control subjects (Area under the curve of Receiver Operating Characteristic over 0.92, in both models; Confidence Interval 0.77-1). In summary, plasma fingerprinting using HF and LF-NMR differentiated TB subjects from uninfected animals, and PTB and PTB-vaccinated subjects who may provide a TB-false positive, highlighting the use of LF-NMR-based metabolomics as a complementary or alternative diagnostic tool to the current diagnostic methods.
- Published
- 2021
5. Molecular survey of Besnoitia spp. (Apicomplexa) in faeces from European wild mesocarnivores in Spain
- Author
-
González-Barrio D, Köster PC, Habela MA, Martín-Pérez M, Fernández-García JL, Balseiro A, Barral M, Nájera F, Figueiredo AM, Palacios MJ, Mateo M, Carmena D, Álvarez-García G, and Calero-Bernal R
- Subjects
TOXOSOURCES - Abstract
Publication, co-authors from JRP-TOXOSOURCES.  
- Published
- 2021
6. Health-related quality of life in men with localized prostate cancer treated with radiotherapy: validation of an abbreviated version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain
- Author
-
Zapatero A, Maldonado Pijoan X, Gómez-Caamaño A, Pardo Masferrer J, Macías Hernández V, Hervás Morón A, Muñoz García JL, Palacios Eito A, Anguita-Alonso P, González-Junco C, and López Torrecilla J
- Subjects
Prostate cancer ,Radiotherapy ,Brachytherapy ,EPIC ,Quality-of-life assessment - Abstract
BACKGROUND: Health-related quality of life (HRQoL) is greatly affected by prostate cancer (PCa) and associated treatments. This study aimed to measure the impact of radiotherapy on HRQoL and to further validate the Spanish version of the 16-item Expanded Prostate Cancer Index Composite (EPIC-16) in routine clinical practice. METHODS: An observational, non-interventional, multicenter study was conducted in Spain with localized PCa patients initiating treatment with external beam radiotherapy (EBRT) or brachytherapy (BQT). Changes from baseline in EPIC-16, University of California-Los Angeles Prostate Cancer Index (UCLA-PCI), and patient-perceived health status were longitudinally assessed at end of radiotherapy (V2) and 90 days thereafter (V3). Psychometric evaluations of the Spanish EPIC-16 were conducted. RESULTS: Of 516 patients enrolled, 495 were included in the analysis (EBRT, n = 361; BQT, n = 134). At baseline, mean (standard deviation [SD]) EPIC-16 global scores were 11.9 (7.5) and 10.3 (7.7) for EBRT and BQT patients, respectively; scores increased, i.e., HRQoL worsened, from baseline, by mean (SD) of 6.8 (7.6) at V2 and 2.4 (7.4) at V3 for EBRT and 4.2 (7.6) and 3.9 (8.2) for BQT patients. Changes in Spanish EPIC-16 domains correlated well with urinary, bowel, and sexual UCLA-PCI domains. EPIC-16 showed good internal consistency (Cronbach's alpha = .84), reliability, and construct validity. CONCLUSION: The Spanish EPIC-16 questionnaire demonstrated sensitivity, strong discriminative properties and reliability, and validity for use in clinical practice. EPIC-16 scores worsened after radiotherapy in different HRQoL domains; however, a strong tendency towards recovery was seen at the 3-month follow-up visit.
- Published
- 2021
7. Implicaciones anestésicas en el Síndrome de Larsen: A propósito de un caso
- Author
-
Jarana Aparicio, Irene, Díaz Lara, Maria Dolores, and Bonilla García, JL
- Subjects
Larsen Syndrome ,difficult airway ,anestesia pediátrica ,vía aérea difícil ,anestesia general ,luxación congénita ,congenital dislocation ,general anesthesia ,Síndrome de Larsen ,pediatric anesthesia - Abstract
Larsen Syndrome (SL) is a rare hereditary disease characterized by a defect in the formation of collagen due to mutations in the genes encoding the cytoskeletal protein filamin B. Its prevalence in Europe is approximately 1 to 250,000 live births. This implies a number of anatomical features of the airway that we must assess in children who are going under anesthesia. We present the case of an 11-year-old boy diagnosed with Larsen syndrome who underwent left ear aticotomy. In this regard, we conducted a literature review on the peculiarities of anesthetic management of these patients., El síndrome de Larsen (SL) es una enfermedad hereditaria rara caracterizada por un defecto en la formación de colágeno debido a mutaciones en los genes que codifican la proteína citoesquelética filamina B. Su prevalencia en Europa es aproximadamente de 1/250.000 nacidos vivos. Esto implica una serie de rasgos y particularidades anatómicas de la vía aérea que debemos valorar en niños que van a ser sometidos a un acto anestésico. Se presenta el caso de un niño de 11 años diagnosticado de síndrome de Larsen que se interviene de aticotomía oído izquierdo. A este propósito, realizamos revisión bibliográfica sobre las peculiaridades del manejo anestésico de estos pacientes.
- Published
- 2020
- Full Text
- View/download PDF
8. Radiofrecuencia convencional de nervios geniculados para en tratamiento de la artrosis de rodilla
- Author
-
Ortega García, JL, Aceña Fabián, V, Ramallo Bravo, A, Portilla Huerta, D, and Lozano Cintado, O
- Subjects
rodilla ,Artrosis ,radiofrecuencia convencional ,neuropatía - Published
- 2020
9. Radiofrecuencia convencional de nervios geniculados para en tratamiento de la artrosis de rodilla
- Author
-
Ortega García,JL, Aceña Fabián,V, Ramallo Bravo,A, Portilla Huerta,D, and Lozano Cintado,O
- Subjects
rodilla ,Artrosis ,radiofrecuencia convencional ,neuropatía - Published
- 2020
10. Health-related quality of life in individuals with metabolic syndrome: A cross-sectional study
- Author
-
Marcos-Delgado A, López-García E, Martínez-González MA, Salas-Salvadó J, Corella D, Fitó M, Romaguera D, Vioque J, Alonso-Gómez AM, Wärnberg J, Martínez JA, Serra-Majem L, Estruch R, Fernández-García JC, Lapetra J, Pintó X, Tur JA, López-Miranda J, Cano-Ibañez N, Delgado-Rodríguez M, Matía-Martín P, Daimiel L, Carriedo E, Vidal J, Vázquez C, Ros E, Lozano-Oloriz E, Bulló M, Sorlí JV, Zomeño MD, Fiol M, González-Palacios S, Sorto-Sánchez C, Pérez-Farinós N, Goñi-Ruiz N, Sanchez-Villegas A, Muñoz-Garach A, Santos-Lozano JM, Galera A, Bouzas C, Toledo E, Babio N, González JI, Del Val-García JL, Moñino M, Martínez-Vergaran MC, Goicolea-Güemez L, Galilea-Zabalza I, Basora J, Muñoz MA, Builf P, Fernández-Villa T, and PREDIMED-Plus investigators
- Subjects
Metabolic Syndrome ,Health-Related ,Well-being ,Quality of Life ,PREDIMED-Plus ,Obesity ,Weight-lass - Abstract
Introduction and objectives: Metabolic syndrome (MetS) is a combination of various cardiovascular risk factors with a major impact on morbidity and premature mortality. However, the impact of MetS on self-reported health-related quality of life (HRQoL) is unknown. This study evaluated the HRQoL in a Spanish adult population aged 55 years and older with MetS. Method: A cross-sectional analysis was performed with baseline data from the PREDIMED-Plus multicentre randomized trial. The participants were 6430 men and women aged 55-75 years with overweight/obesity (body mass index >= 27 and
- Published
- 2020
11. Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization
- Author
-
Gutiérrez, NC, Hernández, JM, García, JL, Cañizo, MC, González, M, Hernández, J, González, MB, García-Marcos, MA, and San Miguel, JF
- Published
- 2001
- Full Text
- View/download PDF
12. Pharmacological and safety evaluation of CIGB-300, a casein kinase 2 inhibitor peptide, administered intralesionally to patients with cervical cancer stage IB2/II
- Author
-
Soriano-García JL, López-Díaz A, Solares-Asteasuainzarra M, Baladrón-Castrillo I, Batista-Albuerne N, García-García I, González-Méndez L, Perera-Negrín Y, Valenzuela-Silva CM, Pedro AP, Quevedo-Sotolongo LS, Hernández-González I, Silveira-Pablos JM, Chong-López A, Alonso DF, Gómez RE, Renault JY, Perrin P, Sigm H, Gold S, Perea-Rodríguez SE, Acevedo-Castro BE, Herrera-Martínez L, and López-Saura PA
- Subjects
Cervical cancer ,Biodistribution ,tumor uptake ,business.industry ,lcsh:R ,lcsh:Medicine ,Pharmacology ,medicine.disease ,histamine ,chemistry.chemical_compound ,B23/nucleophosmin ,Pharmacokinetics ,chemistry ,Toxicity ,CIGB-300 ,Biomarker (medicine) ,Medicine ,Casein kinase 2 ,cervical cancer stage ,business ,pharmacokinetics ,Histamine ,Chemoradiotherapy ,casein kinase - Abstract
CIGB-300 is a pro-apoptotic casein kinase 2 inhibitor peptide with potential anticancer action. An open-label and dose scaling Phase I trial was carried out to investigate the peptide tumor uptake, pharmacokinetics, toxicity, and levels of a CIGB-300 response biomarker in patients with cervical cancer stage IB2/II. Fourteen patients were included; six of them received 35 mg, 6 received 70 mg and the two remaining patients received 245 mg of CIGB-300 prior chemoradiotherapy. CIGB-300 was applied by intratumor injections during 5-consecutive days. For pharmacokinetic and biodistribution studies, the peptide was radiolabeled with 99m Tc in the first administration and whole body gammagraphy and plasma testing were done during 48 h. Data showed that the maximum tolerated dose was 70 mg for CIGB-300 in this clinical setting. Furthermore, an allergic-like syndrome was identified as the dose limiting toxicity, which was well-correlated with plasmatic histamine levels. Importantly, the mean tumor uptake was 14.9 mg and 10.4 mg for CIGB-300 doses of 35 and 70 mg, respectively. Also, the kidneys were the main target organ for drug elimination. Finally, treatment with CIGB-300 significantly reduced the B23/nucleophosmin levels in tumor specimens. CIGB-300 meets potentialities to be tested in future trials in a neoadjuvant setting prior to chemoradiotherapy in cervical cancer.
- Published
- 2013
13. Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial
- Author
-
Mateos MV, Hernández MT, Giraldo P, de la Rubia J, de Arriba F, Corral LL, Rosiñol L, Paiva B, Palomera L, Bargay J, Oriol A, Prosper F, López J, Arguiñano JM, Quintana N, García JL, Bladé J, Lahuerta JJ, and Miguel JF
- Abstract
Background The standard of care for smouldering multiple myeloma is observation. We did the QuiRedex study to compare early treatment with lenalidomide plus dexamethasone with observation in patients with high-risk smouldering multiple myeloma. Here we report the long-term follow-up results of the trial. Methods We did this open-label, randomised, controlled phase 3 study at 19 centres in Spain and three centres in Portugal. Patients aged 18 years or older with high-risk smouldering multiple myeloma were randomly assigned (1: 1), via a computerised random number generator, to receive either early treatment with lenalidomide plus dexamethasone or observation, with dynamic balancing to maintain treatment balance within the two groups. Randomisation was stratified by time from diagnosis of smouldering multiple myeloma to study enrolment (6 months). Patients in the treatment group received nine 4-week induction cycles (lenalidomide 25 mg per day on days 1-21, plus dexamethasone 20 mg per day on days-1-4 and days 12-15), followed by maintenance therapy (lenalidomide 10 mg per day on days 1-21 of each 28-day cycle) up to 2 years. Group allocation was not masked from study investigators or patients. The primary endpoint was time from randomisation to progression to symptomatic myeloma. The primary analysis was based on the per-protocol population, restricted to patients who fulfilled the protocol in terms of eligibility. Safety assessments were based on the intention-to-treat population. This trial is registered with ClinicalTrials.gov, number NCT00480363. Findings Between Nov 8, 2007, and June 9, 2010, 125 patients were enrolled and underwent randomisation. 119 patients comprised the per-protocol population and were randomly assigned to receive either lenalidomide plus dexamethasone (n=57) or observation (n=62). The cutoff date for this update was June 30, 2015. Median follow-up for surviving patients was 75 months (IQR 67-85). Lenalidomide plus dexamethasone continued to provide a benefit on time to progression compared with observation (median time to progression not reached [95% CI 47 months-not reached] vs 23 months [16-31]; hazard ratio [HR] 0.24 [95% CI 0.14-0.41]; p
- Published
- 2016
14. Agua: la importancia de una ingesta adecuada en pediatría
- Author
-
Arredondo-García, JL, primary, Méndez-Herrera, A, additional, Medina-Cortina, H, additional, and Pimentel- Hernández, C, additional
- Published
- 2017
- Full Text
- View/download PDF
15. Hints on the Lateralization of Dopamine Binding to D1 Receptors in Rat Striatum
- Author
-
Franco, R, Casadó-Anguera, V, Muñoz, A, Petrovic, Milos, Navarro, G, Moreno, E, Lanciego, JL, Labandeira-García, JL, Cortés, A, Casadó, V, Franco, R, Casadó-Anguera, V, Muñoz, A, Petrovic, Milos, Navarro, G, Moreno, E, Lanciego, JL, Labandeira-García, JL, Cortés, A, and Casadó, V
- Abstract
Dopamine receptors in striatum are important for healthy brain functioning and are the target of levodopa-based therapy in Parkinson's disease. Lateralization of dopaminergic neurotransmission in striata from different hemispheres occurs in patients, but also in healthy individuals. Our data show that the affinity of dopamine binding to dopamine D1 receptors is significantly higher in left than in right striatum. Analysis of data from radioligand binding to striatal samples from naïve, 6-hydroxydopamine lesioned, levodopa-treated and levodopa-induced dyskinetic rats shows differential receptor structure and gives hints on the causes of right/left lateralization of dopamine binding to striatal D1 receptors. Moreover, binding data showed loss of lateralization in levodopa (L-DOPA)-induced dyskinetic rats.
- Published
- 2016
16. Arbovirus en Latinoamérica
- Author
-
Arredondo-García, JL, primary, Méndez-Herrera, A, additional, and Medina-Cortina, H, additional
- Published
- 2016
- Full Text
- View/download PDF
17. Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma
- Author
-
Mateos MV, Hernández MT, Giraldo P, de la Rubia J, de Arriba F, López Corral L, Rosiñol L, Paiva B, Palomera L, Bargay J, Oriol A, Prosper F, López J, Olavarría E, Quintana N, García JL, Bladé J, Lahuerta JJ, and San Miguel JF
- Subjects
hemic and lymphatic diseases - Abstract
For patients with smoldering multiple myeloma, the standard of care is observation until symptoms develop. However, this approach does not identify high-risk patients who may benefit from early intervention.
- Published
- 2013
18. Consultas ambulatorias de atención especializada. Presente y propuestas de futuro
- Author
-
Zambrana García Jl
- Subjects
Ambulatory care ,business.industry ,medicine ,General Medicine ,Medical emergency ,medicine.disease ,business - Published
- 2004
19. Contenido de alimento y metabolismo ceco-cólico en el tracto digestivo de poblaciones silvestres de iguana negra (Ctenosaura pectinata) en Morelos, México
- Author
-
Vélez-Hernández, L, Cobos-Peralta, MA, and Arcos-García, JL
- Subjects
metabolismo ,parasites ,Ctenosaura pectinata ,digestive tract ,metabolism ,parásitos ,tracto digestivo - Abstract
Five digestive tracts of black lizards (Ctenosaura pectinata) from a wild population were collected in Morelos State, México, in order to identify the plant composition in the diet and the cecum-colic metabolism. Smears obtained from cecum-colic content were observed to register the presence of protozoa, bacteria and intestinal parasites. The average and standard deviation were estimated from the evaluated characteristics. The plants species Guamúchil (Phitecellobium dulce) and Huizache (Acacia farnesiana) were identified in the cecum-colic content. The vegetal content of the diet was constituted by fruits (62.9%), leaves (30.6%), buds (2.9%) and flowers (3.5%), dry matter basis. The cecum-colic portion was characterised by the concentration (mmol) of acetic (68.9 ± 10.6), butyric (11.98 ± 5.7) and propionic (9.04 ± 1.5) fatty acids, total fatty acids (89.9 ± 15), pH 7.45, and ammonia nitrogen concentration (7.4 ± 2.8 mg/dl). The microbiotic observed was theNyctotherus sppprotozoa.The total bacterial count ranged from 7 x 108to 9 x 109/g, cellulolytic bacteria ranged from 9.2 x 107to 3.5 x 108/g of cecal content. The parasites observed were nematodes identified as members of theOxyuroideasuperfamily, with 655 ± 265 eggs/g and 6,300 ± 329 adults/lizard. It is concluded that the fermentation of the cecum-colon region of the adult black iguana behaves similarly to that from herbivorous species, with fermentation being carried out according to the ingested food. Dietary concentration of crude protein was 14.5% and energy 2.193 (Mcal/kg), and they are animals parasited by oxiurids.  , Se colectaron cinco tractos digestivos de iguana negra (Ctenosaura pectinata) en estado silvestre en el estado de Morelos, México, para conocer la composición botánica de la dieta y el metabolismo ceco-cólico. Se observaron frotis realizados del contenido ceco-cólico para registrar la presencia de protozoarios, bacterias y parásitos intestinales existentes. Se obtuvo la media y desviación estándar de las características evaluadas. En el contenido ceco-cólico se identificaron las especies vegetales guamúchil (Phitecellobium dulce) y huizache (Acacia farnesiana). Se estimó en base a materia seca la porción vegetal que conforma la dieta, la cual se distribuyó en frutos (62,9%), hojas (30,6%), rebrotes (2,9%) y flores (3,5%). La región ceco-cólica se caracterizó por la concentración (mmol) de los ácidos grasos acético (68,9 ± 10,6),butírico (11,98 ± 5,7), propiónico (9,04 ± 1,5) y total (89,9 ± 15), con pH de 7,45 y concentración de nitrógeno amoniacal (7,4 ± 2,8 mg/dl). La microbiota que se observó fue el protozoarioNyctotherus spp. Las bacterias totales oscilaron en concentraciones 7 x 10 a 9 x 10/g, siendo las celulolíticas de 9,2 x 10 hasta 3,5 x 10/g de contenido cecal. Los parásitos encontrados son nematodos identificados como miembros de la superfamiliaOxyuroideacon 655 ± 265/g huevos y 6,300 ± 329 adultos/iguana. Se concluye que la fermentación de la región ceco-cólica de la iguana negra en estado adulto se comporta de manera similar como en las especies herbívoras, en las cuales la fermentación se manifiesta de acuerdo con el alimento consumido. La concentración dietaria de proteína cruda fue de 14,5% y energía de 2,193 Mcal/kg y son animales parasitados con oxiuros.  
- Published
- 2012
20. Análisis Del Modelo de Toma de Decisiones Sobre Cobertura de Medicamentos en Chile
- Author
-
García, jL, primary and Silva, NS, additional
- Published
- 2015
- Full Text
- View/download PDF
21. Frequency of nosocomial influenza cases in a tertiary hospital during the 2012-13 to 2014-15 seasons
- Author
-
García, JL Mendoza, primary, Muriel, JG Mora, additional, Iglesias, I Tenza, additional, Shimizu, P García, additional, Perez, M Fuster, additional, Roman, V García, additional, Ares, JL Carretero, additional, El Attabi, M, additional, and Payá, J Sánchez, additional
- Published
- 2015
- Full Text
- View/download PDF
22. Degree of satisfaction of healthcare workers (HCW) with the training received on the use of personal protective equipment (PPE) for the care of patients with suspected Ebola virus disease (EVE): final results
- Author
-
Iglesias, I Tenza, primary, Muriel, JG Mora, additional, Contreras, EJ Silva, additional, García, JL Mendoza, additional, Ruiz, CO Villanueva, additional, Sañudo, J Barrenengoa, additional, Gonzalez, E López, additional, Miro, J Bravo, additional, and Payá, J Sánchez, additional
- Published
- 2015
- Full Text
- View/download PDF
23. PS-065 Analysis of medicines errors made in a general hospital
- Author
-
Lallana, E, primary, Mañes, M, additional, Rubio, B, additional, Vázquez, MJ, additional, García, JL, additional, and Segura, M, additional
- Published
- 2015
- Full Text
- View/download PDF
24. CP-027 Protocolised use of protease inhibitors for hepatitis C in a Health Care Area: 18 months of cost savings
- Author
-
Campos-Davila, E, primary, Ramos-Baez, JJ, additional, Marquez-Fernandez, E, additional, Tellez-Perez, F, additional, Prieto-García, JL, additional, and Guerra-Estevez, D, additional
- Published
- 2014
- Full Text
- View/download PDF
25. PHP37 - Análisis Del Modelo de Toma de Decisiones Sobre Cobertura de Medicamentos en Chile
- Author
-
García, jL and Silva, NS
- Published
- 2015
- Full Text
- View/download PDF
26. Effect of temperature increase on cooling systems in livestock farms
- Author
-
Valiño, V, primary, Perdigones, A, additional, Iglesias, A, additional, and García, JL, additional
- Published
- 2010
- Full Text
- View/download PDF
27. Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen
- Author
-
Zambrana García Jl, Díez García F, and Delgado Fernández M
- Subjects
medicine.medical_specialty ,Naproxen ,business.industry ,Internal medicine ,Toxicity ,Medicine ,Upper gastrointestinal ,General Medicine ,business ,Gastroenterology ,Rofecoxib ,medicine.drug - Published
- 2001
28. Mediastinal germ cell tumour and myelodysplastic syndrome
- Author
-
J. G. Laraña, Rodríguez-García Jl, Fraile G, M. Serrano, and T. Ferro
- Subjects
Pathology ,medicine.medical_specialty ,Letter ,business.industry ,Myelodysplastic syndromes ,medicine ,MEDLINE ,Karyotype ,General Medicine ,medicine.disease ,business ,Germ cell tumour ,Mediastinal Neoplasm - Published
- 1991
29. Infartos cerebrales producidos por material embolizado desde un cuerpo extraño intracardíaco
- Author
-
Medrano-Plana Y, Ibáñez-Azau R, Puig-Reyes I, Lagomasino-Hidalgo Al, Chao-García Jl, Rodríguez-Monteagudo Jl, Bermúdez-Yera G, Moreno-Martínez Fl, Mirabal-Rodríguez R, Llerena-Hernández E, and Vergara-Hidalgo M
- Subjects
Neurology (clinical) ,General Medicine - Published
- 2008
30. Fístula colecistocólica
- Author
-
Sánchez-García Jl, Armengol-Carrasco M, Espin-Basany E, and López-Cano M
- Subjects
medicine.medical_specialty ,Biliary tract ,business.industry ,Medical imaging ,Cholecystocolic fistula ,medicine ,General Medicine ,Radiology ,business - Published
- 2006
31. Letters to the editor
- Author
-
Fraile G, Martinez-San-Millán J, Perales J, Cuesta C, M. Serrano, and Rodríguez-García Jl
- Subjects
Pathology ,medicine.medical_specialty ,Colorectal cancer ,business.industry ,Skull Neoplasm ,Hematology ,medicine.disease ,Metastasis ,Skull ,medicine.anatomical_structure ,Oncology ,medicine ,Paralysis ,Adenocarcinoma ,Cranial nerve disease ,medicine.symptom ,business ,Abducens nerve - Published
- 1992
32. Introduction
- Author
-
Arredondo-García Jl
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,Infectious Diseases ,business.industry ,Internal medicine ,Pediatrics, Perinatology and Child Health ,Sultamicillin ,medicine ,Ampicillin/sulbactam ,business ,medicine.drug - Published
- 1998
33. Carbohydrate intake modulates the effect of the ABCA1-R230C variant on HDL cholesterol concentrations in premenopausal women.
- Author
-
Romero-Hidalgo S, Villarreal-Molina T, González-Barrios JA, Canizales-Quinteros S, Rodríguez-Arellano ME, Yañez-Velazco LB, Bernal-Alcantara DA, Villa AR, Antuna-Puente B, Acuña-Alonzo V, Merino-García JL, Moreno-Sandoval HN, Carnevale A, Romero-Hidalgo, Sandra, Villarreal-Molina, Teresa, González-Barrios, Juan A, Canizales-Quinteros, Samuel, Rodríguez-Arellano, Martha E, Yañez-Velazco, Lucia B, and Bernal-Alcantara, Demetrio A
- Abstract
The R230C variant of the ATP-binding cassette transporter A1 (ABCA1) gene has been consistently associated with decreased HDL-cholesterol (HDL-C) concentrations in several studies in the Mexican mestizo population. However, information on how diet composition modifies the effect of the ABCA1-R230C variant on HDL-C concentrations is very scarce. The aim of the present study was to analyze whether the effect of ABCA1-R230C on HDL-C concentrations is modulated by dietary factors in a nationwide population sample of 3591 adults from the National Health and Nutrition Survey conducted by the State's Employees' Social Security and Social Services Institute. All participants answered a validated questionnaire to assess health status and weekly food consumption. Fasting blood samples were drawn for biochemical analysis and DNA extraction, and the ABCA1-R230C variant was genotyped using TaqMan assays. Statistical analyses consisted of simple linear and multiple regression modeling adjusting for age, BMI, smoking, and alcohol consumption. The overall C risk allele frequency was 9.3% and the variant was significantly associated with low HDL-C concentrations in both sexes. A significant negative correlation between carbohydrate consumption and HDL-C concentrations was observed in women bearing the R230C variant (P = 0.021) and a significant gene-diet interaction was found only in premenopausal women (P = 0.037). In conclusion, the effect of the ABCA1-R230C gene variant on HDL-C concentrations is modulated by carbohydrate intake in premenopausal women. This finding may help design optimized dietary interventions according to sex and ABCA1-R230C genotype. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
34. Racial and ethnic differences in a patient survey: patients' values, ratings, and reports regarding physician primary care performance in a large health maintenance organization.
- Author
-
Murray-García JL, Selby JV, Schmittdiel J, Grumbach K, Quesenberry CP Jr., Murray-García, J L, Selby, J V, Schmittdiel, J, Grumbach, K, and Quesenberry, C P Jr
- Published
- 2000
- Full Text
- View/download PDF
35. PHP37 Análisis Del Modelo de Toma de Decisiones Sobre Cobertura de Medicamentos en Chile
- Author
-
García, jL and Silva, NS
- Full Text
- View/download PDF
36. Antimicrobial activity data in support of nitrofurantoin three times per day.
- Author
-
Amábile-Cuevas CF and Arredondo-García JL
- Published
- 2011
- Full Text
- View/download PDF
37. Upper gastrointestinal toxicity of rofecoxib and naproxen.
- Author
-
Delgado Fernández M, Zambrana García JL, and Diez García F
- Published
- 2001
38. Thermal transpiration of CO 2 at high temperature
- Author
-
Garcia, JL, González de Prado, JE, González Tejuca, L, and Pajares, JA
- Published
- 1975
- Full Text
- View/download PDF
39. Efficacy and safety of aflibercept in metastatic colorectal cancer pretreated with bevacizumab: A report of five cases
- Author
-
Margarita Garrido, Teresa Pereda, Isabel Blancas, José Miguel Jurado, Marta Legerén, José Luis García, Mayte Delgado, Julia Alcaide, María J. Sánchez, Antonio Rueda, Jorge López, [Alcaide,J, Rueda,A] Oncology Department, Costa del Sol Hospital, Marbella, Málaga, Spain. [Delgado,M, Legerén,M, Jurado,JM, Blancas,I, Sánchez,MJ, García,JL] Oncology Department, San Cecilio Clinical Hospital, Granada, Andalucía, Spain. [Pereda,T, López,J] Pathology Department, Costa del Sol Hospital, Marbella, Málaga, Spain. [Garrido,M] Pharmacy and Nutrition Department, Costa del Sol Hospital, Marbella, Málaga, Spain., [Alcaide, Julia] Costa Sol Hosp, Dept Oncol, Malaga 29603, Spain, [Rueda, Antonio] Costa Sol Hosp, Dept Oncol, Malaga 29603, Spain, [Delgado, Mayte] San Cecilio Clin Hosp, Dept Oncol, Dr Oloriz Ave, Granada 18014, Andalucia, Spain, [Legeren, Marta] San Cecilio Clin Hosp, Dept Oncol, Dr Oloriz Ave, Granada 18014, Andalucia, Spain, [Jurado, Jose Miguel] San Cecilio Clin Hosp, Dept Oncol, Dr Oloriz Ave, Granada 18014, Andalucia, Spain, [Blancas, Isabel] San Cecilio Clin Hosp, Dept Oncol, Dr Oloriz Ave, Granada 18014, Andalucia, Spain, [Sanchez, Maria J.] San Cecilio Clin Hosp, Dept Oncol, Dr Oloriz Ave, Granada 18014, Andalucia, Spain, [Garcia, Jose L.] San Cecilio Clin Hosp, Dept Oncol, Dr Oloriz Ave, Granada 18014, Andalucia, Spain, [Pereda, Teresa] Costa Sol Hosp, Dept Pathol, Malaga 29603, Spain, [Lopez, Jorge] Costa Sol Hosp, Dept Pathol, Malaga 29603, Spain, [Garrido, Margarita] Costa Sol Hosp, Pharm & Nutr Dept, Malaga 29603, Spain, and Sanofi Spain (Barcelona, Spain)
- Subjects
0301 basic medicine ,Oncology ,Cancer Research ,Colorectal cancer ,Leucovorin ,Chemicals and Drugs::Heterocyclic Compounds::Alkaloids::Camptothecin [Medical Subject Headings] ,Ras mutations ,Targeted therapy ,Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings] ,angiogenesis ,1st progression ,0302 clinical medicine ,Neoplasias colorrectales ,Camptotecina ,Ensayos de Uso compasivo ,Aflibercept ,Proteínas recombinantes de fusión ,Metastatic colorectal cancer ,Chemicals and Drugs::Organic Chemicals::Organometallic Compounds::Organoplatinum Compounds [Medical Subject Headings] ,metastatic colorectal cancer ,aflibercept ,Articles ,targeted therapy ,VEGF ,Humanos ,Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Recombinant Proteins::Recombinant Fusion Proteins [Medical Subject Headings] ,Proteinuria ,030220 oncology & carcinogenesis ,Chemicals and Drugs::Macromolecular Substances::Polymers::Polyesters [Medical Subject Headings] ,Combination ,Diseases::Hemic and Lymphatic Diseases::Hematologic Diseases::Leukocyte Disorders::Leukopenia::Agranulocytosis::Neutropenia [Medical Subject Headings] ,Fluorouracil ,Compuestos organoplatinos ,medicine.drug ,medicine.medical_specialty ,Phenomena and Processes::Genetic Phenomena::Genetic Variation::Mutation [Medical Subject Headings] ,Bevacizumab ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Therapies, Investigational::Compassionate Use Trials [Medical Subject Headings] ,Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Tyrosine Kinases::Receptor Protein-Tyrosine Kinases::Receptors, Vascular Endothelial Growth Factor [Medical Subject Headings] ,Guidelines ,Neutropenia ,Irinotecan ,Association ,Xenograft models ,03 medical and health sciences ,VEGFR ,Diseases::Cardiovascular Diseases::Vascular Diseases::Hypertension [Medical Subject Headings] ,Internal medicine ,Hipertensión ,medicine ,Chemotherapy ,Supervivencia sin enfermedad ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Disease-Free Survival [Medical Subject Headings] ,Mutación ,business.industry ,Diseases::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms [Medical Subject Headings] ,Receptores de Factores de crecimiento endotelial vascular ,medicine.disease ,Oxaliplatin ,Surgery ,Clinical trial ,Regimen ,Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Urological Manifestations::Proteinuria [Medical Subject Headings] ,030104 developmental biology ,Angiogenesis ,Poliésteres ,business - Abstract
Journal Article; Aflibercept is a recombinant fusion protein that acts by inhibiting tumoural angiogenesis. Efficacy data obtained in the VELOUR randomised study has contributed to the approval of aflibercept as a second-line metastatic colorectal cancer (mCRC) treatment following an oxaliplatin-based regimen. The present study reports a case series of five patients with mCRC, who were treated in two centres since 2011 in the Compassionate Use Program for aflibercept. All patients had a KRAS mutation and previously received palliative fluoropyrimidine-oxaliplatin-based chemotherapy with bevacizumab. A doublet with irinotecan combined with aflibercept was administered until progression of disease. The majority of patients received a greater number of aflibercept cycles than the median reported in the VELOUR study (12 vs. 7 cycles), with manageable and reversible toxicity. The most frequent adverse events observed were diarrhoea, neutropenia, fatigue, proteinuria and hypertension. Most cases obtained a progression-free survival greater than the median reported in the VELOUR study (11 vs. 6.9 months) and, in a subgroup of patients previously treated with bevacizumab, and a median survival time of ~47 months was reached from the initial treatment of the disease. The present study contrasts the efficacy and safety results obtained from the pivotal VELOUR trial, and confirms that aflibercept, used in routine clinical practice outside of the clinical trial environment, is active and well-tolerated following bevacizumab treatment. Medical writing assistance, supported financially by Sanofi Spain (Barcelona, Spain). Yes
- Published
- 2016
40. Smart polymers and smartphones for Betalain measurement in cooked beetroots.
- Author
-
Gaona-Ruiz M, Vallejo-García JL, Arnaiz A, Sedano-Labrador C, Trigo-López M, Rodríguez A, Carrillo C, and Vallejos S
- Subjects
- Cooking, Plant Roots chemistry, Colorimetry, Betalains chemistry, Betalains analysis, Beta vulgaris chemistry, Polymers chemistry, Smartphone
- Abstract
Betalains in beetroots offer notable colouring properties and health benefits, including antioxidant, anti-inflammatory, hepatoprotective, and antitumorous activities. However, they degrade due to processing and storage conditions like temperature, pH, oxygen, and light-exposure. Traditional betalain determination methods are resource-intensive solid-liquid extractions. This study proposes a novel approach using a smart polymer to rapidly quantify betalains in processed beetroots. The polymer, containing N,N-dimethylaminoethyl methacrylate, selectively interacts with compounds like betalains. Characterization shows thermal stability over 250 °C and suitable mechanical properties. The film changes to colour upon interaction with betalains, allowing quantification via smartphone. The sensory polymer's efficacy was validated across 27 beetroot samples, showing no significant differences compared to traditional methods. Combining the smart polymer with a colour analysis app, "Colorimetric Titration," provides a robust and efficient means of quantifying total betalains in beetroot puree, reducing the quantification time from 180 to 90 min, promising implications for routine food industry quality assessments., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
41. Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons.
- Author
-
Rivas-Santisteban R, Muñoz A, Lillo J, Raïch I, Rodríguez-Pérez AI, Navarro G, Labandeira-García JL, and Franco R
- Abstract
Calcium ion (Ca
2+ ) homeostasis is crucial for neuron function and neurotransmission. This study focused on the actions mediated by the CB1 receptor (CB1 R), the most abundant G protein-coupled receptor (GPCR) in central nervous system (CNS) neurons, over by the AT1 R, which is one of the few G protein-coupled CNS receptors able to regulate cytoplasmic Ca2+ levels. A functional interaction suggesting a direct association between these receptors was detected. AT1 -CB1 receptor heteromers (AT1 CB1 Hets) were identified in HEK-293T cells by bioluminescence resonance energy transfer (BRET2 ). Functional interactions within the AT1 -CB1 complex and their potential relevance in Parkinson's disease (PD) were assessed. In situ proximity ligation assays (PLA) identified AT1 CB1 Hets in neurons, in which an important finding was that Ca2+ level increase upon AT1 R activation was reduced in the presence of cannabinoids acting on CB1 Rs. AT1 CB1 Het expression was quantified in samples from the 6-hydroxydopamine (6-OHDA) hemilesioned rat model of PD in which a lower expression of AT1 CB1 Hets was observed in striatal neurons from lesioned animals (versus non-lesioned). AT1 CB1 Het expression changed depending on both the lesion and the consequences of levodopa administration, i.e., dyskinesias versus lack of involuntary movements. A partial recovery in AT1 CB1 Het expression was detected in lesioned animals that developed levodopa-induced dyskinesias. These findings support the existence of a compensatory mechanism mediated by AT1 CB1 Hets that modulates susceptibility to levodopa-induced dyskinesias in PD. Therefore, cannabinoids may be useful in reducing calcium dyshomeostasis in dyskinesia., Competing Interests: Competing interests The authors declare no competing interests. Ethical approval Animal handling, sacrifice, and further experiments were conducted according to the guidelines set in Directive 2010/63/EU of the European Parliament and the Council of the European Union that are enforced in Spain by National and Regional organisms; the 3R rule (replace, refine, reduce) for animal experimentation was also considered. The rat PD model was generated and handled using a protocol approved by the Ethical Committee of the University of Santiago de Compostela (Protocol 14715012/2021/012; last revision 16 April 2021). According to the current legislation, protocol approval is unnecessary if animals are sacrificed to obtain a specific tissue as in this work to obtain primary neurons., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
42. Nicotinamide and pyridoxine stimulate muscle stem cell expansion and enhance regenerative capacity during aging.
- Author
-
Ancel S, Michaud J, Migliavacca E, Jomard C, Fessard A, Garcia P, Karaz S, Raja S, Jacot GE, Desgeorges T, Sánchez-García JL, Tauzin L, Ratinaud Y, Brinon B, Métairon S, Pinero L, Barron D, Blum S, Karagounis LG, Heshmat R, Ostovar A, Farzadfar F, Scionti I, Mounier R, Gondin J, Stuelsatz P, and Feige JN
- Abstract
Skeletal muscle relies on resident muscle stem cells (MuSCs) for growth and repair. Aging and muscle diseases impair MuSC function, leading to stem cell exhaustion and regenerative decline that contribute to the progressive loss of skeletal muscle mass and strength. In the absence of clinically available nutritional solutions specifically targeting MuSCs, we used a human myogenic progenitor (hMP) high-content imaging screen of natural molecules from food to identify nicotinamide (NAM) and pyridoxine (PN) as bioactive nutrients that stimulate MuSCs and have history of safe human use. NAM and PN synergize via CK1-mediated cytoplasmic β-catenin activation and AKT signaling to promote amplification and differentiation of MuSCs. Oral treatment with a combination of NAM/PN accelerates muscle regeneration in vivo by stimulating MuSCs, increases muscle strength during recovery, and overcomes MuSC dysfunction and regenerative failure during aging. Levels of NAM and bioactive PN spontaneously decline during aging in model organisms and inter-independently associate with muscle mass and walking speed in a human cohort of 186 aged people. Collectively, our results establish NAM/PN as a new nutritional intervention that stimulates MuSCs, enhances muscle regeneration, and alleviates age-related muscle decline with a direct opportunity for clinical translation.
- Published
- 2024
- Full Text
- View/download PDF
43. Granulometric and Geochemical Distribution of Arsenic in a Mining Environmental Liability in a Semi-arid Area.
- Author
-
Mora-Sánchez FJ, Gómez-Álvarez A, Encinas-Romero MA, Valenzuela-García JL, Jara-Marini ME, Encinas-Soto KK, Villalba-Atondo AI, and Dórame-Carreño G
- Abstract
This study focuses on the "El Lavadero" tailings deposit, a mining environmental liability (MEL) located near the town of San Felipe de Jesús, Sonora, in northwest Mexico. The objective was to determine the total arsenic (As) content, its granulometric and geochemical distribution, as well as its mobilization capacity and bioavailability. The results from oxidized and unoxidized tailings showed low potential of hydrogen (pH) values (2.4-5.7) and high concentrations of total arsenic (8235-36,004 mg kg
-1 ), predominantly in the finer granulometric fractions (< 0.05 mm). Arsenic also prevails in the finest fraction of agricultural soil (> 2 mm). These fine particles could present adverse environmental effects due to their potential to be transported by leaching and water suspension. In contrast, arsenic in the effluent sediments is primarily found in the coarser fraction (> 2 mm). A significant proportion of arsenic in the tailings (5-40%) was found in the non-residual geochemical fractions (I + II + III) (1106-7675 mg kg-1 ), indicating potential for mobilization and bioavailability. Depending on environmental conditions (redox potential and pH), arsenic can redissolve and exhibit high mobility in abiotic media, which may ultimately impact the environment and human health. Therefore, it is crucial to rehabilitate the "El Lavadero" MEL to prevent further environmental damage. This study provides useful information to understand some phenomena in other global mining environmental liabilities, such as mobilization and bioavailability of arsenic and its possible impact on the surrounding environment and biota, contributing to the worldwide research of ecosystems polluted by mining activity, especially in arid and semi-arid climates., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)- Published
- 2024
- Full Text
- View/download PDF
44. Phosphorylation of cytosolic hPGK1 affects protein stability and ligand binding: implications for its subcellular targeting in cancer.
- Author
-
Pacheco-García JL, Cano-Muñoz M, Loginov DS, Vankova P, Man P, and Pey AL
- Subjects
- Humans, Phosphorylation, Ligands, Protein Stability, Thermodynamics, Kinetics, Adenosine Diphosphate metabolism, Mutation, Molecular Dynamics Simulation, Neoplasms genetics, Neoplasms metabolism, Neoplasms pathology, Cytosol metabolism, Protein Binding, Phosphoglycerate Kinase metabolism, Phosphoglycerate Kinase genetics, Phosphoglycerate Kinase chemistry
- Abstract
Human phosphoglycerate kinase 1(hPGK1) is a key glycolytic enzyme that regulates the balance between ADP and ATP concentrations inside the cell. Phosphorylation of hPGK1 at S203 and S256 has been associated with enzyme import from the cytosol to the mitochondria and the nucleus respectively. These changes in subcellular locations drive tumorigenesis and are likely associated with site-specific changes in protein stability. In this work, we investigate the effects of site-specific phosphorylation on thermal and kinetic stability and protein structural dynamics by hydrogen-deuterium exchange (HDX) and molecular dynamics (MD) simulations. We also investigate the binding of 3-phosphoglycerate and Mg-ADP using these approaches. We show that the phosphomimetic mutation S256D reduces hPGK1 kinetic stability by 50-fold, with no effect of the mutation S203D. Calorimetric studies of ligand binding show a large decrease in affinity for Mg-ADP in the S256D variant, whereas Mg-ADP binding to the WT and S203D can be accurately investigated using protein kinetic stability and binding thermodynamic models. HDX and MD simulations confirmed the destabilization caused by the mutation S256D (with some long-range effects on stability) and its reduced affinity for Mg-ADP due to the strong destabilization of its binding site (particularly in the apo-state). Our research provides evidence suggesting that modifications in protein stability could potentially enhance the translocation of hPGK1 to the nucleus in cancer. While the structural and energetic basis of its mitochondrial import remain unknown., (© 2024 The Author(s). The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.)
- Published
- 2024
- Full Text
- View/download PDF
45. SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts.
- Author
-
Martínez-López A, Infante G, Mendiburu-Eliçabe M, Machuca A, Antón OM, González-Fernández M, Luque-García JL, Clarke RB, and Castillo-Lluva S
- Abstract
Background: Cancer-associated fibroblasts (CAFs) are the most abundant stromal cellular component in the tumor microenvironment (TME). CAFs contribute to tumorigenesis and have been proposed as targets for anticancer therapies. Similarly, dysregulation of SUMO machinery components can disrupt the balance of SUMOylation, contributing to tumorigenesis and drug resistance in various cancers, including breast cancer. We explored the role of SUMOylation in breast CAFs and evaluated its potential as a therapeutic strategy in breast cancer., Methods: We used pharmacological and genetic approaches to analyse the functional crosstalk between breast tumor cells and CAFs. We treated breast CAFs with the SUMO1 inhibitor ginkgolic acid (GA) at two different concentrations and conditioned media was used to analyse the proliferation, migration, and invasion of breast cancer cells from different molecular subtypes. Additionally, we performed quantitative proteomics (SILAC) to study the differential signalling pathways expressed in CAFs treated with low or high concentrations of GA. We confirmed these results both in vitro and in vivo. Moreover, we used samples from metastatic breast cancer patients to evaluate the use of GA as a therapeutic strategy., Results: Inhibition of SUMOylation with ginkgolic acid (GA) induces death in breast cancer cells but does not affect the viability of CAFs, indicating that CAFs are resistant to this therapy. While CAF viability is unaffected, CAF-conditioned media (CM) is altered by GA, impacting tumor cell behaviour in different ways depending on the overall degree to which SUMO1-SUMOylated proteins are dysregulated. Breast cancer cell lines exhibited a concentration-dependent response to conditioned media (CM) from CAFs. At a low concentration of GA (10 µM), there was an increase in proliferation, migration and invasion of breast cancer cells. However, at a higher concentration of GA (30 µM), these processes were inhibited. Similarly, analysis of tumor development revealed that at 10 µM of GA, the tumors were heavier and there was a greater degree of metastasis compared to the tumors treated with the higher concentration of GA (30 µM). Moreover, some of these effects could be explained by an alteration in the activity of the GTPase Rac1 and the activation of the AKT signalling pathway. The results obtained using SILAC suggest that different concentrations of GA affected cellular processes differentially, possibly influencing the secretome of CAFs. Treatment of metastatic breast cancer with GA demonstrated the use of SUMOylation inhibition as an alternative therapeutic strategy., Conclusion: The study highlights the importance of SUMOylation in the tumor microenvironment, specifically in cancer-associated fibroblasts (CAFs). Targeting SUMOylation in CAFs affects their signalling pathways and secretome in a concentration-dependent manner, regulating the protumorigenic properties of CAFs., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
46. Facilitators and barriers to perform physical activity in patients post-heart transplantation: a qualitative study.
- Author
-
Klompstra L, Perkïo Kato N, Almenar-Bonet L, Cabanillas-García JL, Del Brío-Alonso I, Moreno-Segura N, Sánchez-Gómez MC, López-Vilella R, and Marques-Sule E
- Abstract
Aim: Most patients experience barriers for becoming physical active post-heart transplantation. Therefore, identifying barriers and facilitators can help healthcare professionals in developing physical activity programs. This study aimed to explore the physical activity experiences, perceived barriers, and facilitators to perform physical activity of patients' post-heart transplantation., Methods and Results: A qualitative study was carried out using in-depth semi-structured interviews on 24 patients post-heart transplantation from October to December 2022. The data were analyzed using an inductive strategy for finding emerging themes. NVivo 12.0 software was used to analyze the data. The physical activity experiences included that (1) patients felt that they had to adapt to a new situation after the heart transplantation, (2) walking was a popular physical activity preferably outdoors, (3) participants preferred to perform physical activity regularly with others, and (4) they felt better since they perform physical activity. The facilitators were: (1) Desire to live; (2) Experiencing physical benefits; (3) Being physically active with others; (4) Use of mobility assistive devices resources. The barriers were: (1) Feeling not being able to perform former physical activity; (2) Complications and experiencing symptoms post-heart transplantation; (3) Unfavourable climate., Conclusions: Patients post-heart transplantation have various facilitators influencing their post-transplant experience to perform physical activity. Key facilitators include the desire to live, physical benefits, social activity, and external support. Yet, they also face barriers like lost abilities, post-transplant complications, and environmental challenges., (© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
47. Early education's long-term benefits.
- Author
-
García JL
- Published
- 2024
- Full Text
- View/download PDF
48. Thromboembolic phenomena in inflammatory bowel disease and risk with JAK inhibitor treatments.
- Author
-
Rueda García JL, Benitez JM, Baston Rey I, Calafat Sard M, and Suárez Ferrer C
- Published
- 2024
- Full Text
- View/download PDF
49. Regulation of Safracin Biosynthesis and Transport in Pseudomonas poae PMA22.
- Author
-
Hernández Delgado JG, Acedos MG, de la Calle F, Rodríguez P, García JL, and Galán B
- Subjects
- Promoter Regions, Genetic, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents biosynthesis, Biological Transport, Operon, Pseudomonas metabolism, Pseudomonas genetics, Multigene Family, Bacterial Proteins metabolism, Bacterial Proteins genetics, Gene Expression Regulation, Bacterial
- Abstract
Pseudomonas poae PMA22 produces safracins, a family of compounds with potent broad-spectrum anti-bacterial and anti-tumor activities. The safracins' biosynthetic gene cluster (BGC sac) consists of 11 ORFs organized in two divergent operons ( sacABCDEFGHK and sacIJ ) that are controlled by P
a and Pi promoters. Contiguous to the BGC sac, we have located a gene that encodes a putative global regulator of the LysR family annotated as MexT that was originally described as a transcriptional activator of the MexEF-OprN multidrug efflux pump in Pseudomonas . Through both in vitro and in vivo experiments, we have demonstrated the involvement of the dual regulatory system MexT-MexS on the BGC sac expression acting as an activator and a repressor, respectively. The MexEF-OprN transport system of PMA22, also controlled by MexT, was shown to play a fundamental role in the metabolism of safracin. The overexpression of mexEF-oprN in PMA22 resulted in fourfold higher production levels of safracin. These results illustrate how a pleiotropic regulatory system can be critical to optimizing the production of tailored secondary metabolites, not only through direct interaction with the BGC promoters, but also by controlling their transport.- Published
- 2024
- Full Text
- View/download PDF
50. Intergenerational effects of maternal childhood maltreatment on newborns' stress regulation: The role of maternal depressive symptoms.
- Author
-
San Martín-González N, Moya-Higueras J, Eixarch E, Castro-Quintas Á, Marques-Feixa L, Crispi F, Daura-Corral M, de la Fuente-Tomás L, Monteserín-García JL, García-Portilla MP, and Fañanás L
- Subjects
- Humans, Female, Adult, Infant, Newborn, Pregnancy, Adult Survivors of Child Abuse psychology, Mothers psychology, Male, Saliva chemistry, Saliva metabolism, Hypothalamo-Hypophyseal System metabolism, Pituitary-Adrenal System metabolism, Object Attachment, Depression, Postpartum psychology, Young Adult, Mother-Child Relations psychology, Hydrocortisone metabolism, Stress, Psychological, Depression psychology
- Abstract
Background: Maternal childhood maltreatment (CM) has been repeatedly associated with negative offspring's emotional outcomes. The dysregulation of the Hypothalamic-Pituitary-Adrenal (HPA) axis has emerged as the main underlying physiological mechanism., Objective: To explore the association between maternal CM and newborns' physiological and neurobehavioral stress responses, considering the role of perinatal maternal depression and bonding., Participants and Setting: 150 healthy women were followed throughout pregnancy. 79 mother-infant dyads were included in the final analyses. Maternal CM was evaluated using the Childhood Trauma Questionnaire and depressive symptoms by the Edinburgh Postnatal Depression Scale (EPDS) at each trimester. At 7 weeks postpartum, the EPDS and the Postpartum Bonding Questionnaire were administered. Newborns' behavioral responses were assessed using "States Organization" (SO) and "States Regulation" (SR) subdomains of the Neonatal Behavioral Assessment Scale (NBAS). Newborns' salivary samples were collected before and after the NBAS to study cortisol reactivity., Methods: A cross-lagged panel model was employed., Results: Infants born to mothers with higher CM presented more optimal scores on SO (β (0.635) = 0.216, p 〈001) and SR (ß (0.273) = 0.195, p = .006), and a higher cortisol reactivity after NBAS handling (β(0.019) = 0.217, p = .009). Moreover, newborns of mothers with higher CM and postpartum depressive symptoms exhibited a poorer performance on SR (ß (0.156 = -0.288,p = .002). Analyses revealed non-significant relationships between mother-infant bonding, newborns' cortisol reactivity and SO., Conclusions: Newborns from mothers with greater CM present higher cortisol reactivity and more optimal behavioral responses, which may reflect a prenatal HPA axis sensitization. However, those exposed to maternal postnatal depressive symptoms present poorer stress recovery., Competing Interests: Declaration of competing interest Authors declare no conflict of interest., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.